Evidence map›Paper›PMID 34655865›Full record

ArticleMedical image analysis2021

BrainGNN: Interpretable Brain Graph Neural Network for fMRI Analysis.

Xiaoxiao Li, Yuan Zhou, Nicha Dvornek, Muhan Zhang, Siyuan Gao, Juntang Zhuang, Dustin Scheinost, Lawrence H Staib, Pamela Ventola, James S Duncan

Abstract read
In one paragraph

Article in Medical image analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. [Research on weighted hypergraph attention neural network for the diagnosis of psychiatric disorders using brain functional connectivity networks].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoxiao LiBiomedical Engineering, Yale University, New Haven, CT, 06511, USA; Electrical and Computer Engineering, The University of British Columbia, Vancouver, BC, V6T1Z4, Canada. Electronic address: xiaoxiao.li@aya.yale.edu.
Yuan ZhouRadiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06511, USA.
Nicha DvornekBiomedical Engineering, Yale University, New Haven, CT, 06511, USA; Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06511, USA.
Muhan ZhangFacebook AI Research, CA, USA.
Siyuan GaoBiomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Juntang ZhuangBiomedical Engineering, Yale University, New Haven, CT, 06511, USA.
Dustin ScheinostRadiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06511, USA.
Lawrence H StaibBiomedical Engineering, Yale University, New Haven, CT, 06511, USA; Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06511, USA.
Pamela VentolaChild Study Center, Yale School of Medicine, New Have, CT, 06511, USA.
James S DuncanBiomedical Engineering, Yale University, New Haven, CT, 06511, USA; Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, 06511, USA; Electrical Engineering, Yale University, New Haven, CT, 06511, USA; Statistics & Data Science, Yale University, New Haven, CT, 06511, USA. Electronic address: james.duncan@yale.edu.

Funding

Subnetwork-based Quantitative Imaging Biomarkers for Therapy Assessment in AutismR01NS035193 · NINDS · YALE UNIVERSITY · PI JAMES S DUNCAN, LAWRENCE H. STAIB · 1996 to 2026
$9.2M
NINDS NIH HHS R01 NS035193
6 · The paper itself

Abstract

Understanding which brain regions are related to a specific neurological disorder or cognitive stimuli has been an important area of neuroimaging research. We propose BrainGNN, a graph neural network (GNN) framework to analyze functional magnetic resonance images (fMRI) and discover neurological biomarkers. Considering the special property of brain graphs, we design novel ROI-aware graph convolutional (Ra-GConv) layers that leverage the topological and functional information of fMRI. Motivated by the need for transparency in medical image analysis, our BrainGNN contains ROI-selection pooling layers (R-pool) that highlight salient ROIs (nodes in the graph), so that we can infer which ROIs are important for prediction. Furthermore, we propose regularization terms-unit loss, topK pooling (TPK) loss and group-level consistency (GLC) loss-on pooling results to encourage reasonable ROI-selection and provide flexibility to encourage either fully individual- or patterns that agree with group-level data. We apply the BrainGNN framework on two independent fMRI datasets: an Autism Spectrum Disorder (ASD) fMRI dataset and data from the Human Connectome Project (HCP) 900 Subject Release. We investigate different choices of the hyper-parameters and show that BrainGNN outperforms the alternative fMRI image analysis methods in terms of four different evaluation metrics. The obtained community clustering and salient ROI detection results show a high correspondence with the previous neuroimaging-derived evidence of biomarkers for ASD and specific task states decoded for HCP. Our code is available at https://github.com/xxlya/BrainGNN_Pytorch.

Indexed as

Autism Spectrum DisorderConnectomeBrainHumansMagnetic Resonance ImagingNeural Networks, ComputerASDBiomarkerfMRIGNN

Identifiers

PMID34655865
PMCPMC9916535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.